Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1661-1680 of 2,360 trials

Genetic Assessment of Early to Late Macular Degeneration Study

NCT01464710

The purpose of this study is to determine if polymorphisms at rs11200638 on HTRA1 and rs1061170 on CFH are associated with an accelerated progression to advanced AMD (wet AMD or GA) in patients with early AMD (soft confluent drusen\>120 microns ) in the study eye, and with either early AMD or advanced AMD in the non-study eye.

Age-related Macular Degeneration

Henry Ferreyra170 participantsStarted Apr 2008

La Jolla, California, United States • Santa Barbara, California, United States • San Antonio, Texas, United States

TERMINATEDEARLY Phase 1< 1 mile

Low Dose Vasopressin in Traumatic Shock

NCT00420407

Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

InjuriesShock, Traumatic

The University of Texas Health Science Center at San Antonio81 participantsStarted Feb 2007

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Irritable Bowel Syndrome Characterized by Constipation

Bausch Health Americas, Inc.1,054 participantsStarted Dec 2014

Athens, Alabama, United States • Birmingham, Alabama, United States • Dothan, Alabama, United States +152 more locations

Genetic Assessment of Early to Late Macular Degeneration Study

Low Dose Vasopressin in Traumatic Shock

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Rheumatoid Arthritis Trials in Other Cities

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

The Chimerix CMX001 Registry

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

The Respiratory Protection Effectiveness Clinical Trial

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

MEmbranous Nephropathy Trial Of Rituximab

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Other Conditions in San Antonio